128 related articles for article (PubMed ID: 340084)
41. Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.
Vokes EE; Haraf DJ; Panje WR; Schilsky RL; Weichselbaum RR
Semin Oncol; 1992 Jun; 19(3 Suppl 9):53-8. PubMed ID: 1641658
[TBL] [Abstract][Full Text] [Related]
42. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract][Full Text] [Related]
43. Radiation therapy in hyperbaric oxygen for head and neck cancer at Royal Adelaide Hospital--1964 to 1980.
Denham JW; Yeoh EK; Wittwer G; Ward GG; Ahmad AS; Harvey ND
Int J Radiat Oncol Biol Phys; 1987 Feb; 13(2):201-8. PubMed ID: 3818386
[TBL] [Abstract][Full Text] [Related]
44. Management of advanced head and neck squamous cell carcinoma in elderly patients.
Awada A; de Castro G
Curr Opin Oncol; 2006 May; 18(3):225-7. PubMed ID: 16552232
[No Abstract] [Full Text] [Related]
45. [Chemoradiotherapy for patients with advanced head and neck cancer].
Tsukuda M
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
[TBL] [Abstract][Full Text] [Related]
46. [Metronidazole in radiotherapy of squamous cell carcinoma of the lung].
Zolkiver KI; Muchambetova GA; Toktamysova ZS
Radiobiol Radiother (Berl); 1986; 27(6):691-9. PubMed ID: 3575677
[No Abstract] [Full Text] [Related]
47. The end of the hypoxic EPOch.
Aguilera TA; Giaccia AJ
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):895-7. PubMed ID: 25832683
[No Abstract] [Full Text] [Related]
48. Impact of anemia in patients with head and neck cancer.
Kumar P
Oncologist; 2000; 5 Suppl 2():13-8. PubMed ID: 10896324
[TBL] [Abstract][Full Text] [Related]
49. [DAHANCA (Danish Head and Neck Cancer)--20 years of cooperation].
Hansen HS; Overgaard J; Jørgensen KE
Ugeskr Laeger; 1998 Feb; 160(6):821-6. PubMed ID: 9469979
[TBL] [Abstract][Full Text] [Related]
50. [Effectiveness of the radiosensitizer cisplatin. A pilot study].
Klima A; Szepesi S
Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):457-9. PubMed ID: 3683038
[TBL] [Abstract][Full Text] [Related]
51. Cytotoxicity of two nitroimidazole radiosensitizers in an in vitro tumor model.
Sridhar R; Koch C; Suterland R
Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1149-57. PubMed ID: 993091
[No Abstract] [Full Text] [Related]
52. [Radiosensitivity and/or radioresistance of head and neck cancers: Biological angle].
Guy JB; Rancoule C; Méry B; Espenel S; Wozny AS; Simonet S; Vallard A; Alphonse G; Ardail D; Rodriguez-Lafrasse C; Magné N
Bull Cancer; 2016 Jan; 103(1):41-7. PubMed ID: 26702507
[TBL] [Abstract][Full Text] [Related]
53. Intravenous delivery of 5'-iododeoxyuridine during hyperfractionated radiotherapy for locally advanced head and neck cancers: results of a pilot study.
Epstein AH; Lebovics RS; Van Waes C; Smith J; Okunieff P; Cook JA
Laryngoscope; 1998 Jul; 108(7):1090-4. PubMed ID: 9665262
[TBL] [Abstract][Full Text] [Related]
54. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent.
Hicks RJ; Rischin D; Fisher R; Binns D; Scott AM; Peters LJ
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1384-91. PubMed ID: 16133382
[TBL] [Abstract][Full Text] [Related]
55. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.
Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P
Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480
[No Abstract] [Full Text] [Related]
56. [Quality of life after simultaneous radiochemotherapy in squamous cell carcinoma of the head and neck].
Wendt TG
Strahlenther Onkol; 2000 Apr; 176(4):198-200. PubMed ID: 10812396
[No Abstract] [Full Text] [Related]
57. Beyond detection: novel applications for PET imaging to guide cancer therapy.
Rajendran JG; Mankoff DA
J Nucl Med; 2007 Jun; 48(6):855-6. PubMed ID: 17536105
[No Abstract] [Full Text] [Related]
58. Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7).
Pradier O; Rave-Fränk M; Schmidberger H; Bömecke M; Lehmann J; Meden H; Hess CF
J Cancer Res Clin Oncol; 1999; 125(1):20-7. PubMed ID: 10037273
[TBL] [Abstract][Full Text] [Related]
59. [Three cases of head and neck cancer made resectable by hyperthermo-chemo-radiotherapy].
Fujimura T; Yonemura Y; Kamata T; Takegawa S; Sugiyama K; Nishimura G; Miyata R; Yamaguchi A; Miyazaki I; Nakajima K
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1322-7. PubMed ID: 3430022
[No Abstract] [Full Text] [Related]
60. Neurotoxic radiosensitizers and head and neck cancer patients--how many will benefit?
Cummings BJ; Thomas GM; Rauth AM; Sorrenti V; Black B; Bush RS
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):343-5. PubMed ID: 7107351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
